Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: Findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM) - 28/07/13
, Gregg C. Fonarow, MD c, Xiaojuan Mi, PhD a, W. Frank Peacock, MD d, Roger M. Mills, MD e, Lesley H. Curtis, PhD a, b, Laura G. Qualls, MS a, Adrian F. Hernandez, MD, MHS a, bRésumé |
Background |
Timing of initial treatment for acute decompensated heart failure (ADHF) varies across hospitals and its impact on outcomes remains poorly defined. We examined the association between time to first intravenous (IV) heart failure (HF) therapy and patient outcomes.
Methods |
Using the ADHERE-EM linked to Medicare claims data, we identified patients ≥65 years old who were hospitalized for ADHF and received IV HF therapy during index admission. Cox proportional hazard model was used to assess the association of time to treatment with a composite of 30-day all-cause mortality or re-admission. Generalized linear mixed models were used to examine the association of time to treatment with in-hospital all-cause mortality, index hospitalization length of stay, and total days alive and out-of-hospital at 30 days.
Results |
Of 6,971 patients, the median time to first IV HF therapy was 2.3-hours (interquartile range 1.1, 4.4). The cumulative incidence of 30-day all-cause mortality or readmission was 27.4%. After adjusting for covariates, time to treatment was not associated with increased risk of composite 30-day all-cause mortality or re-admission (HR 1.00; 95% CI 1.00-1.00; P = .221). However, every hour delay in treatment was associated with a modest increased risk of in-hospital mortality (adjusted OR 1.01; 95% CI 1.00-1.02; P = .001) and an approximately 1.4-hour increase in index admission length of stay (P < .001).
Conclusion |
Among older patients presenting with ADHF, delay in initiating IV HF therapy was associated with modestly higher risk for in-hospital mortality and longer length of stay, but was not associated with 30-day outcomes.
Le texte complet de cet article est disponible en PDF.Plan
| Hector O. Ventura, MD served as guest editor for this article. |
Vol 166 - N° 2
P. 349-356 - août 2013 Retour au numéro
Article précédent
- Left bundle-branch block: The relationship between electrocardiogram electrical activation and echocardiography mechanical contraction
- Niels Risum, David Strauss, Peter Sogaard, Zak Loring, Thomas Fritz Hansen, Niels Eske Bruun, Galen Wagner, Joseph Kisslo
- Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized prospective trial (VitD-CHF trial)
- Nicolas F. Schroten, Willem P.T. Ruifrok, Lennaert Kleijn, Martin M. Dokter, Herman H. Silljé, Hiddo J. Lambers Heerspink, Stephan J.L. Bakker, Ido P. Kema, Wiek H. van Gilst, Dirk J. van Veldhuisen, Hans L. Hillege, Rudolf A. de Boer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?